© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Ligand Pharmaceuticals Incorporated (LGND) shows an Average True Range (ATR) of 8 and an Enterprise Value of 1.24B. Its average trading volume over the past 3 months is 349.39K, indicating liquidity. These fundamental metrics provide insight into LGND's underlying financial health and market activity.
| ATR | 8 |
| Enterprise Value | 1.24B |
| Avg Vol (3 Months) | 349.39K |
| Avg Vol (10 Days) | 171.44K |
Ligand Pharmaceuticals Incorporated (LGND) technical indicators as of September 4, 2026: the SMA 20 is 3.31%, SMA 50 at 1.22%, and SMA 200 at 19.48%. The RSI 14 value is 56.64, suggesting its current momentum. These technical analysis signals help assess LGND's price trends and potential future movements.
| SMA 20 | 3.31% |
| SMA 50 | 1.22% |
| SMA 200 | 19.48% |
| RSI 14 | 56.64 |
Ligand Pharmaceuticals Incorporated (LGND) stock performance overview as of September 4, 2026: The 52-week high is $326.63 (currently -7.68% below), and the 52-week low is $161.82 (currently 109.63% above). Over the past year, LGND's performance is 76.95%, compared to the S&P 500's 1.58% change.
| 52-Week High | 326.63 |
| 52-Week High Chg | -7.68% |
| 52-Week Low | 161.82 |
| 52-Week Low Chg | +109.63% |
| S&P 500 52-Week Chg | 1.58% |
According to market data, Ligand Pharmaceuticals Incorporated (LGND) stock's recent performance metrics show that over the last month, LGND is 1.01%, with a Year-to-Date (YTD) performance of 3.96%. Over the past year, the stock has seen a 76.95% change. These figures summarize LGND's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 290.41 | 304.6 | 326.63 | 326.63 | 326.63 | 326.63 |
| Low | 275.6 | 275.6 | 236.09 | 178.72 | 161.82 | 175.89 |
| Performance | -4.96% | +1.01% | +8.21% | +39.29% | +76.95% | +3.96% |
According to current financial data, LGND stock's P/E (TTM) ratio is 28.72, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.25. Key valuation ratios for LGND, including P/S (19.83), P/B (5.96), and P/FCF (43.86), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | LGND | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | 28.72 | -1.25 | -194.36 | 32.59 |
| P/S (TTM) | 19.83 | 3.71 | 467.56 | 5.98 |
| P/B (TTM) | 5.96 | 1.42 | 16.39 | 5.77 |
| P/FCF (TTM) | 43.86 | -1.96 | -754.77 | 29.62 |